BAKER BROS. ADVISORS LP

Average Profitability
7.01%
Insider Buys Quantity
122
Insider Buys Sum
$2.35B
Insider Sells Quantity
20
Insider Sells Sum
$88.3M

Insider Activity of BAKER BROS. ADVISORS LP

According to the SEC Form 4 filings, BAKER BROS. ADVISORS LP, being in a position of

  1. at Bicycle Therapeutics plc,
    оver the last 12 months, has bought 1485397 shares for $21.23M, and sold 0 shares,
    over all time since 2024-12-13, has bought 1485397 shares for $21.23M, and sold 0 shares.

The largest purchase of all time was on 2018-11-30 and amounted to 23529410 shares of ACADIA Pharmaceuticals Inc. for $400M.

The largest sale of all time was on 2016-08-12 and amounted to 7291200 shares of BioCryst Pharmaceuticals, Inc. for $36.63M.

Biography of BAKER BROS. ADVISORS LP

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$26,656,0007100
Sells
$000

Comparison of Insiders on Amount of Buys and Sells

2024-12-30PurchaseKala Pharmaceuticals, Inc.
KALA
10 percent owner
310,559
6.2153%
$6.44$2M+11.94%
2024-12-16PurchaseBicycle Therapeutics plc
BCYC
500,000
0.7341%
$15.34$7.67M-3.44%
2024-12-13PurchaseBicycle Therapeutics plc
BCYC
985,397
1.3409%
$13.76$13.56M+6.01%
2024-08-20PurchaseKymera Therapeutics, Inc.
KYMR
director
1
<0.0001%
$46.41$46-0.63%
2024-03-28PurchaseIGM Biosciences, Inc.
IGMS
97,473
0.1653%
$9.62$937,632-1.87%
2024-03-27PurchaseIGM Biosciences, Inc.
IGMS
27,844
0.0472%
$9.24$257,170+2.16%
2024-03-26PurchaseIGM Biosciences, Inc.
IGMS
270,000
0.4372%
$8.26$2.23M+9.1%
2023-12-15PurchaseIGM Biosciences, Inc.
IGMS
288,007
0.5123%
$6.55$1.89M+60.28%
2023-12-14PurchaseIGM Biosciences, Inc.
IGMS
157,370
0.2689%
$6.50$1.02M+55.31%
2023-12-14PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
director
20,633
0.102%
$228.32$4.71M+1.94%
2023-12-13PurchaseIGM Biosciences, Inc.
IGMS
87,316
0.1427%
$5.96$520,776+61.74%
2023-12-13PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
director
81,159
0.3998%
$219.39$17.81M+5.74%
2023-12-12PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
director
34,578
0.1727%
$218.31$7.55M+7.38%
2023-11-21PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
director
64,350
0.3268%
$188.47$12.13M+25.19%
2023-11-20PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
director
20,709
0.1027%
$185.74$3.85M+24.39%
2023-11-17PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
director
46,370
0.233%
$174.70$8.1M+34.1%
2023-11-15PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
director
15,199
0.0766%
$161.97$2.46M+43.52%
2023-11-14PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
director
71,848
0.361%
$155.15$11.15M+50.11%
2023-11-13PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
director
69,839
0.3486%
$143.21$10M+60.44%
2023-06-26PurchaseIGM Biosciences, Inc.
IGMS
director
5.63M
$0$0-7.21%
Total: 142
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
USD